Compounded Bioidentical Hormone Therapy Market, Global Outlook and Forecast 2022-2028
Bioidentical hormones are artificial hormones that are chemically similar to those naturallyproduced by the human body. Because they are chemically similar to the hormones produced by the body, bioidentical hormones act as the body's own hormones with very few side effects.
This report contains market size and forecasts of Compounded Bioidentical Hormone Therapy in global, including the following market information:
Global Compounded Bioidentical Hormone Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Compounded Bioidentical Hormone Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Compounded Bioidentical Hormone Therapy companies in 2021 (%)
The global Compounded Bioidentical Hormone Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oestrogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Compounded Bioidentical Hormone Therapy include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Compounded Bioidentical Hormone Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Compounded Bioidentical Hormone Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Type, 2021 (%)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Application, 2021 (%)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Compounded Bioidentical Hormone Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Compounded Bioidentical Hormone Therapy revenues share in global market, 2021 (%)
Key companies Compounded Bioidentical Hormone Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Compounded Bioidentical Hormone Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Compounded Bioidentical Hormone Therapy in global, including the following market information:
Global Compounded Bioidentical Hormone Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Compounded Bioidentical Hormone Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Compounded Bioidentical Hormone Therapy companies in 2021 (%)
The global Compounded Bioidentical Hormone Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oestrogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Compounded Bioidentical Hormone Therapy include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Compounded Bioidentical Hormone Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Compounded Bioidentical Hormone Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Type, 2021 (%)
- Oestrogen
- Progesterone
- Testosterone
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Compounded Bioidentical Hormone Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Compounded Bioidentical Hormone Therapy revenues share in global market, 2021 (%)
Key companies Compounded Bioidentical Hormone Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Compounded Bioidentical Hormone Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- SottoPelle
- BioTE Medical
- Advantage Pharmaceuticals
- Full Life Wellness Center
- Neuva Aesthetics
- Defy Medical
- Bio station
- Noven Pharmaceuticals
- Novartis AG
- Pfizer
- TherapeuticsMD
- Bayer AG
- Novo Nordisk
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Compounded Bioidentical Hormone Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Compounded Bioidentical Hormone Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COMPOUNDED BIOIDENTICAL HORMONE THERAPY OVERALL MARKET SIZE
2.1 Global Compounded Bioidentical Hormone Therapy Market Size: 2021 VS 2028
2.2 Global Compounded Bioidentical Hormone Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Compounded Bioidentical Hormone Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Compounded Bioidentical Hormone Therapy Players in Global Market
3.2 Top Global Compounded Bioidentical Hormone Therapy Companies Ranked by Revenue
3.3 Global Compounded Bioidentical Hormone Therapy Revenue by Companies
3.4 Global Compounded Bioidentical Hormone Therapy Sales by Companies
3.5 Global Compounded Bioidentical Hormone Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Compounded Bioidentical Hormone Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Players in Global Market
3.8.1 List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Compounded Bioidentical Hormone Therapy Market Size Markets, 2021 & 2028
4.1.2 Oestrogen
4.1.3 Progesterone
4.1.4 Testosterone
4.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
4.2.1 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
4.2.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
4.2.3 By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
4.3.1 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
4.3.2 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
4.3.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Compounded Bioidentical Hormone Therapy Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
5.2.1 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
5.2.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
5.2.3 By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
5.3.1 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
5.3.2 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
5.3.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Compounded Bioidentical Hormone Therapy Market Size, 2021 & 2028
6.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
6.2.1 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
6.2.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
6.2.3 By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
6.3.1 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
6.3.2 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
6.3.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.4.2 By Country - North America Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.4.3 US Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.4.4 Canada Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.4.5 Mexico Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.5.3 Germany Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.4 France Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.5 U.K. Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.6 Italy Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.7 Russia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.9 Benelux Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.6.3 China Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.4 Japan Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.5 South Korea Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.7 India Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.7.2 By Country - South America Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.7.3 Brazil Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.7.4 Argentina Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.8.3 Turkey Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.4 Israel Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.6 UAE Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SottoPelle
7.1.1 SottoPelle Corporate Summary
7.1.2 SottoPelle Business Overview
7.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Major Product Offerings
7.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.1.5 SottoPelle Key News
7.2 BioTE Medical
7.2.1 BioTE Medical Corporate Summary
7.2.2 BioTE Medical Business Overview
7.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.2.5 BioTE Medical Key News
7.3 Advantage Pharmaceuticals
7.3.1 Advantage Pharmaceuticals Corporate Summary
7.3.2 Advantage Pharmaceuticals Business Overview
7.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Advantage Pharmaceuticals Key News
7.4 Full Life Wellness Center
7.4.1 Full Life Wellness Center Corporate Summary
7.4.2 Full Life Wellness Center Business Overview
7.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Major Product Offerings
7.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Full Life Wellness Center Key News
7.5 Neuva Aesthetics
7.5.1 Neuva Aesthetics Corporate Summary
7.5.2 Neuva Aesthetics Business Overview
7.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Major Product Offerings
7.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Neuva Aesthetics Key News
7.6 Defy Medical
7.6.1 Defy Medical Corporate Summary
7.6.2 Defy Medical Business Overview
7.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Defy Medical Key News
7.7 Bio station
7.7.1 Bio station Corporate Summary
7.7.2 Bio station Business Overview
7.7.3 Bio station Compounded Bioidentical Hormone Therapy Major Product Offerings
7.7.4 Bio station Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Bio station Key News
7.8 Noven Pharmaceuticals
7.8.1 Noven Pharmaceuticals Corporate Summary
7.8.2 Noven Pharmaceuticals Business Overview
7.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Noven Pharmaceuticals Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Novartis AG Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Compounded Bioidentical Hormone Therapy Major Product Offerings
7.10.4 Pfizer Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 TherapeuticsMD
7.11.1 TherapeuticsMD Corporate Summary
7.11.2 TherapeuticsMD Compounded Bioidentical Hormone Therapy Business Overview
7.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Major Product Offerings
7.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.11.5 TherapeuticsMD Key News
7.12 Bayer AG
7.12.1 Bayer AG Corporate Summary
7.12.2 Bayer AG Compounded Bioidentical Hormone Therapy Business Overview
7.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Bayer AG Key News
7.13 Novo Nordisk
7.13.1 Novo Nordisk Corporate Summary
7.13.2 Novo Nordisk Compounded Bioidentical Hormone Therapy Business Overview
7.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Major Product Offerings
7.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Novo Nordisk Key News
8 GLOBAL COMPOUNDED BIOIDENTICAL HORMONE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Compounded Bioidentical Hormone Therapy Production Capacity, 2017-2028
8.2 Compounded Bioidentical Hormone Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Compounded Bioidentical Hormone Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 COMPOUNDED BIOIDENTICAL HORMONE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Compounded Bioidentical Hormone Therapy Industry Value Chain
10.2 Compounded Bioidentical Hormone Therapy Upstream Market
10.3 Compounded Bioidentical Hormone Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Compounded Bioidentical Hormone Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Compounded Bioidentical Hormone Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COMPOUNDED BIOIDENTICAL HORMONE THERAPY OVERALL MARKET SIZE
2.1 Global Compounded Bioidentical Hormone Therapy Market Size: 2021 VS 2028
2.2 Global Compounded Bioidentical Hormone Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Compounded Bioidentical Hormone Therapy Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Compounded Bioidentical Hormone Therapy Players in Global Market
3.2 Top Global Compounded Bioidentical Hormone Therapy Companies Ranked by Revenue
3.3 Global Compounded Bioidentical Hormone Therapy Revenue by Companies
3.4 Global Compounded Bioidentical Hormone Therapy Sales by Companies
3.5 Global Compounded Bioidentical Hormone Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Compounded Bioidentical Hormone Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Players in Global Market
3.8.1 List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Compounded Bioidentical Hormone Therapy Market Size Markets, 2021 & 2028
4.1.2 Oestrogen
4.1.3 Progesterone
4.1.4 Testosterone
4.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
4.2.1 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
4.2.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
4.2.3 By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
4.3.1 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
4.3.2 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
4.3.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Compounded Bioidentical Hormone Therapy Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
5.2.1 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
5.2.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
5.2.3 By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
5.3.1 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
5.3.2 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
5.3.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Compounded Bioidentical Hormone Therapy Market Size, 2021 & 2028
6.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
6.2.1 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2022
6.2.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2023-2028
6.2.3 By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
6.3.1 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2017-2022
6.3.2 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2023-2028
6.3.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.4.2 By Country - North America Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.4.3 US Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.4.4 Canada Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.4.5 Mexico Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.5.3 Germany Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.4 France Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.5 U.K. Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.6 Italy Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.7 Russia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.5.9 Benelux Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.6.3 China Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.4 Japan Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.5 South Korea Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.6.7 India Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.7.2 By Country - South America Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.7.3 Brazil Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.7.4 Argentina Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, 2017-2028
6.8.3 Turkey Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.4 Israel Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
6.8.6 UAE Compounded Bioidentical Hormone Therapy Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SottoPelle
7.1.1 SottoPelle Corporate Summary
7.1.2 SottoPelle Business Overview
7.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Major Product Offerings
7.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.1.5 SottoPelle Key News
7.2 BioTE Medical
7.2.1 BioTE Medical Corporate Summary
7.2.2 BioTE Medical Business Overview
7.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.2.5 BioTE Medical Key News
7.3 Advantage Pharmaceuticals
7.3.1 Advantage Pharmaceuticals Corporate Summary
7.3.2 Advantage Pharmaceuticals Business Overview
7.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Advantage Pharmaceuticals Key News
7.4 Full Life Wellness Center
7.4.1 Full Life Wellness Center Corporate Summary
7.4.2 Full Life Wellness Center Business Overview
7.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Major Product Offerings
7.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Full Life Wellness Center Key News
7.5 Neuva Aesthetics
7.5.1 Neuva Aesthetics Corporate Summary
7.5.2 Neuva Aesthetics Business Overview
7.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Major Product Offerings
7.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Neuva Aesthetics Key News
7.6 Defy Medical
7.6.1 Defy Medical Corporate Summary
7.6.2 Defy Medical Business Overview
7.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Defy Medical Key News
7.7 Bio station
7.7.1 Bio station Corporate Summary
7.7.2 Bio station Business Overview
7.7.3 Bio station Compounded Bioidentical Hormone Therapy Major Product Offerings
7.7.4 Bio station Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Bio station Key News
7.8 Noven Pharmaceuticals
7.8.1 Noven Pharmaceuticals Corporate Summary
7.8.2 Noven Pharmaceuticals Business Overview
7.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Noven Pharmaceuticals Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Novartis AG Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Compounded Bioidentical Hormone Therapy Major Product Offerings
7.10.4 Pfizer Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 TherapeuticsMD
7.11.1 TherapeuticsMD Corporate Summary
7.11.2 TherapeuticsMD Compounded Bioidentical Hormone Therapy Business Overview
7.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Major Product Offerings
7.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.11.5 TherapeuticsMD Key News
7.12 Bayer AG
7.12.1 Bayer AG Corporate Summary
7.12.2 Bayer AG Compounded Bioidentical Hormone Therapy Business Overview
7.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Bayer AG Key News
7.13 Novo Nordisk
7.13.1 Novo Nordisk Corporate Summary
7.13.2 Novo Nordisk Compounded Bioidentical Hormone Therapy Business Overview
7.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Major Product Offerings
7.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2017-2022)
7.13.5 Novo Nordisk Key News
8 GLOBAL COMPOUNDED BIOIDENTICAL HORMONE THERAPY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Compounded Bioidentical Hormone Therapy Production Capacity, 2017-2028
8.2 Compounded Bioidentical Hormone Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Compounded Bioidentical Hormone Therapy Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 COMPOUNDED BIOIDENTICAL HORMONE THERAPY SUPPLY CHAIN ANALYSIS
10.1 Compounded Bioidentical Hormone Therapy Industry Value Chain
10.2 Compounded Bioidentical Hormone Therapy Upstream Market
10.3 Compounded Bioidentical Hormone Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Compounded Bioidentical Hormone Therapy in Global Market
Table 2. Top Compounded Bioidentical Hormone Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Compounded Bioidentical Hormone Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Compounded Bioidentical Hormone Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Compounded Bioidentical Hormone Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Compounded Bioidentical Hormone Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Compounded Bioidentical Hormone Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
Table 9. List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 46. SottoPelle Corporate Summary
Table 47. SottoPelle Compounded Bioidentical Hormone Therapy Product Offerings
Table 48. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. BioTE Medical Corporate Summary
Table 50. BioTE Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 51. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Advantage Pharmaceuticals Corporate Summary
Table 53. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 54. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Full Life Wellness Center Corporate Summary
Table 56. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Offerings
Table 57. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Neuva Aesthetics Corporate Summary
Table 59. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Offerings
Table 60. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Defy Medical Corporate Summary
Table 62. Defy Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 63. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Bio station Corporate Summary
Table 65. Bio station Compounded Bioidentical Hormone Therapy Product Offerings
Table 66. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Noven Pharmaceuticals Corporate Summary
Table 68. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 69. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis AG Corporate Summary
Table 71. Novartis AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 72. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Compounded Bioidentical Hormone Therapy Product Offerings
Table 75. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. TherapeuticsMD Corporate Summary
Table 77. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Offerings
Table 78. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Bayer AG Corporate Summary
Table 80. Bayer AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 81. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Novo Nordisk Corporate Summary
Table 83. Novo Nordisk Compounded Bioidentical Hormone Therapy Product Offerings
Table 84. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Compounded Bioidentical Hormone Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Compounded Bioidentical Hormone Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Compounded Bioidentical Hormone Therapy Production by Region, 2017-2022 (K Units)
Table 88. Global Compounded Bioidentical Hormone Therapy Production by Region, 2023-2028 (K Units)
Table 89. Compounded Bioidentical Hormone Therapy Market Opportunities & Trends in Global Market
Table 90. Compounded Bioidentical Hormone Therapy Market Drivers in Global Market
Table 91. Compounded Bioidentical Hormone Therapy Market Restraints in Global Market
Table 92. Compounded Bioidentical Hormone Therapy Raw Materials
Table 93. Compounded Bioidentical Hormone Therapy Raw Materials Suppliers in Global Market
Table 94. Typical Compounded Bioidentical Hormone Therapy Downstream
Table 95. Compounded Bioidentical Hormone Therapy Downstream Clients in Global Market
Table 96. Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global Market
Table 1. Key Players of Compounded Bioidentical Hormone Therapy in Global Market
Table 2. Top Compounded Bioidentical Hormone Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Compounded Bioidentical Hormone Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Compounded Bioidentical Hormone Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Compounded Bioidentical Hormone Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Compounded Bioidentical Hormone Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Compounded Bioidentical Hormone Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
Table 9. List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2023-2028
Table 46. SottoPelle Corporate Summary
Table 47. SottoPelle Compounded Bioidentical Hormone Therapy Product Offerings
Table 48. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. BioTE Medical Corporate Summary
Table 50. BioTE Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 51. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Advantage Pharmaceuticals Corporate Summary
Table 53. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 54. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Full Life Wellness Center Corporate Summary
Table 56. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Offerings
Table 57. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Neuva Aesthetics Corporate Summary
Table 59. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Offerings
Table 60. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Defy Medical Corporate Summary
Table 62. Defy Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 63. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Bio station Corporate Summary
Table 65. Bio station Compounded Bioidentical Hormone Therapy Product Offerings
Table 66. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Noven Pharmaceuticals Corporate Summary
Table 68. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 69. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Novartis AG Corporate Summary
Table 71. Novartis AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 72. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Compounded Bioidentical Hormone Therapy Product Offerings
Table 75. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. TherapeuticsMD Corporate Summary
Table 77. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Offerings
Table 78. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Bayer AG Corporate Summary
Table 80. Bayer AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 81. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Novo Nordisk Corporate Summary
Table 83. Novo Nordisk Compounded Bioidentical Hormone Therapy Product Offerings
Table 84. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Compounded Bioidentical Hormone Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Compounded Bioidentical Hormone Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Compounded Bioidentical Hormone Therapy Production by Region, 2017-2022 (K Units)
Table 88. Global Compounded Bioidentical Hormone Therapy Production by Region, 2023-2028 (K Units)
Table 89. Compounded Bioidentical Hormone Therapy Market Opportunities & Trends in Global Market
Table 90. Compounded Bioidentical Hormone Therapy Market Drivers in Global Market
Table 91. Compounded Bioidentical Hormone Therapy Market Restraints in Global Market
Table 92. Compounded Bioidentical Hormone Therapy Raw Materials
Table 93. Compounded Bioidentical Hormone Therapy Raw Materials Suppliers in Global Market
Table 94. Typical Compounded Bioidentical Hormone Therapy Downstream
Table 95. Compounded Bioidentical Hormone Therapy Downstream Clients in Global Market
Table 96. Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Compounded Bioidentical Hormone Therapy Segment by Type
Figure 2. Compounded Bioidentical Hormone Therapy Segment by Application
Figure 3. Global Compounded Bioidentical Hormone Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Compounded Bioidentical Hormone Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Compounded Bioidentical Hormone Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Compounded Bioidentical Hormone Therapy Revenue in 2021
Figure 9. By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 19. US Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 24. Germany Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 33. China Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Compounded Bioidentical Hormone Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Compounded Bioidentical Hormone Therapy by Region, 2021 VS 2028
Figure 50. Compounded Bioidentical Hormone Therapy Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Compounded Bioidentical Hormone Therapy Segment by Type
Figure 2. Compounded Bioidentical Hormone Therapy Segment by Application
Figure 3. Global Compounded Bioidentical Hormone Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Compounded Bioidentical Hormone Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Compounded Bioidentical Hormone Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Compounded Bioidentical Hormone Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Compounded Bioidentical Hormone Therapy Revenue in 2021
Figure 9. By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 19. US Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 24. Germany Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 33. China Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Compounded Bioidentical Hormone Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Compounded Bioidentical Hormone Therapy by Region, 2021 VS 2028
Figure 50. Compounded Bioidentical Hormone Therapy Industry Value Chain
Figure 51. Marketing Channels
